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acute pancreatitis (n=3). At study entry, 14 (74%) patients were
in the ICU (median Simplified Acute Physiology Score II 45, range
31-65), 19 (100%) received antibacterial therapy and 17 (89%) were
colonized with Candida (C. albicans in 69%; CCI ≥0.4 in 1/17 case,
5%). Median duration of CSP Px was 16 days (range 4-46). During
CSP Px, 17 (89%) patients remained colonized (C. albicans in 68%),
but 0/17 developed a CCI ≥0.4. CSP was successful for prevention
of IC in 18 (95%) patients. Among 5 deaths, none was attributed
to IC. No severe CSP-related SAE requiring discontinuation of Px
occurred.
Discussion: The results of this pilot study suggest that caspofungin
is efficacious and safe for prophylaxis of intra-abdominal candidia-
sis in high-risk surgical patients.
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Objectives: The aim of this study was to evaluate the incidence of
microbial pathogens isolated from cultures of venous catheter tips
(VCT) and determine their susceptibility patterns to antimicrobial
agents from patients hospitalized in the intensive care unit (ICU).
Methods: During a four year period (2003-2007) 925 VCT were cul-
tured from patients hospitalized in the ICU of our hospital. Patients
between 18-60 years aged and were hospitalized for more than 48
hours. Specimens were cultured and evaluated according to the
semi-quantitative method (MAKI' S) for aerobic microorganisms and
fungi. Antibiotic susceptibility testing was performed by the agar
disk diffusion method according to CLSI guidelines.
Results: From 925 VCT cultures 158 (17%) were positive. Of them
23% grew Acinetobacter baumanii, 22% Pseudomonas aeruginosa,
26% Enterobacteriaceae, 6% Enterococcus spp., 3% Staphylococcus
aureus, 16% Staphylococcus coagulase-negative and 3% Candida
spp. 74% of A. baumanii and Ps. aeruginosa strains were resistant
to Carbapanems, 69% to Gentamycin and 81% to Amikacin.
Twenty-six percent of Enterobacteriaceae strains were resistant to
Carbapenems, 24% to Gentamycin and 48% to Amikacin. From S. au-
reus and Staphylococcus coagulase-negative isolated strains 60%
and 66% respectively were resistant to Methicilin. 22% of Entero-
coccus spp. were resistant to Vancomycin and Teicoplanin (van A).
Conclusions: A. baumanii and Ps. aeruginosa were the most
common isolated pathogens followed by Staphylococci coagulase-
negative. An elevated percentage of multiresistant strains was ob-
served. The knowledge of the resident microbial flora and their
antimicrobial susceptibility profiles is necessary in order to formu-
late a rational policy in patients with catheter devices.
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Background: Enterococci may not be the main pathogens associ-
ated with Intensive Care Unit (ICU) patients infections but their
increasing resistance rates to many commonly administrated an-
tibiotics often leads to the need of using a combination of an-
timicrobial agents when dealing with these infections. Even though
aminoglycosides used alone have very low efficiency against these
microorganisms, their combination with an antibiotic that targets
bacterial cell wall has proved to be successful. Testing for high
level aminoglycoside resistance (HLAR) is a laboratory means of
evaluating the efficiency of such a combination.
Objectives: To assess antimicrobial susceptibility rates and HLAR
of Enterococcus strains isolated from ICU patients during one year
period of time.
Methods: Between 01-01-2007 and 31-12-2007, 50 Enterococcus
strains were isolated from different ICU patients' samples (mainly
bronchial aspirates, urine, blood and wounds). Identification of
bacteria was made by standard laboratory proceedings and suscep-
tibility testing to antimicrobial agents was performed with the disk
diffusion test (Kirby-Bauer method) along with the miniAPI system.
HLAR test was performed with the disk diffusion test according to
the CLSI guidelines with the use of 120 microgram Gentamicin and
300 microgram Streptomycin disks.
Results: Enterococcus faecium was the most frequent enterococ-
cal isolate (40%), followed by Ent. faecalis (32%), Ent. casseliflavus
(12%), Ent. gallinarum (12%) and Ent. durans (4%). All strains
were susceptible to vancomycin and teicoplanin while susceptibil-
ity rates for quinupristin-dalfopristin were for Ent. faecium 40%,
Ent. faecalis 0%, Ent. casseliflavus 0%, Ent. gallinarum 66.6% and
Ent. durans 0%. HLAR is shown in the following table.
Gentamicin 120µg Streptomycin 300µg
(R %) (R %)
Ent. faecium 60 90
Ent. faecalis 50 50
Ent. casseliflavus 33.3 33.3
Ent. gallinarum 0 33.3
Ent. durans 100 100
Conclusions: Glycopeptides remain highly efficient while strep-
togramins showed lower efficiency. Enterococci species isolated
from ICU patients had high HLAR rates especially in the case of
Ent. faecium, Ent. faecalis and Ent. durans. Since high level resis-
tance to aminoglycosides means that these antibiotics will not be
synergistic with cell-wall-active agents, testing for HLAR is impor-
tant for the proper therapeutical approach of these patients.
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Background: Gram-negative bacteria are the main pathogens asso-
ciated with Intensive Care Unit (ICU) patients infections and their
increasing resistance rates to multiple antimicrobial agents con-
tribute to high morbidity and mortality rates.
Objectives: To assess susceptibility rates to carbapenems and
aminoglycosides of the most frequently isolated Gram-negative
bacteria from ICU clinical specimens.
Methods: During one year period of time (1/1/2007 till
31/12/2007) 409 Gram-negative bacterial strains were recovered
from different samples obtained from ICU patients (including
bronchial aspirates, urine, central venous catheters, blood and
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wounds). Bacterial identification was made by routine laboratory
proceedings while susceptibility testing was performed with the
disk diffusion method according to the CLSI guidelines as well as
with the miniAPI system.
Results: Pseudomonas aeruginosa, Acinetobacter baumannii and
Klebsiella pneumoniae were the most frequently isolated G-
negative bacteria, their prevalence of isolation being 26.6%, 26.1%
and 24.4% respectively. Isolation rates for the rest of the microor-
ganisms were: E. coli 6.11%, Proteus mirabilis 4.4%, Enterobac-
ter cloacae 2.44%, Klebsiella oxytoca 2.44%, Serratia marcescens
1.9% and Stenotrophomonas maltophilia 1.4%. Susceptibility rates
to carbapenems and aminoglycosides are shown in Table 1.
Table 1
S %
Imipenem Meropenem Amikacin Tobramycin
Ps. aeruginosa 51.3 49.5 61.4 57.7
Acin. baumannii 5.6 9.8 0 0
Kl. pneumoniae 46 46 67.6 20.4
E. coli 100 100 88 88
Pr. mirabilis 100 100 100 100
Ent. cloacae 100 100 100 100
Kl. oxytoca 80 80 100 70
Ser. marcescens 100 100 87.5 87.5
Sten. maltophilia 0 0 0 0
Conclusions: Acin. baumannii and Sten. maltophilia showed the
lower susceptibility rates to tested antibiotics, while Ps. aerug-
inosa and Kl. pneumoniae had medium susceptibility rates. For
the rest of the bacterial strains carbapenems and aminiglycosides
proved to remain efficient. Increasing resistance rates to car-
bapenems and aminoglycosides among some of the most frequently
isolated Gram-negative pathogens from ICU patients underscores
the importance of susceptibility surveillance and the appropriate
use of antimicrobial agents.
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Background: Bloodstream infections (BSI) are the predominant
type of nosocomial infections in Intensive Care Unit (ICU). Mul-
tiresistant (MDR) bacteria pose a serious threat to the outcome of
ICU patients, especially of those that are immunocompromised.
Objectives: To collect and analyze data of all intrahospital BSI in
immunocompromised patients in a polyvalent 10-bed ICU of a ter-
tiary care hospital.
Methods: All BSI episodes that occurred in ICU patients between
Aug 2006 and Feb 2008 were studied. Blood samples were obtained
on clinical suspicion of BSI, followed-up on signs of changes in clin-
ical and laboratory status.
Results: Among 376 patients that were admitted to an ICU during
18 months, 29 episodes of BSI occurred in 21 immunocompromised
patients. Their clinical data were: mean age 57.5±15.1 years,
mean APACHE II score 28±10.8 and ICU length of stay 24.21±1
days. 7 patients had undergone solid organ transplantation, 7 pa-
tients suffered from malignant disease, 6 were diabetics and 1 was
on long-term corticosteroids. 21 of the BSIs were considered pri-
mary bacteremias while 8 were catheter-related. 4 were due to
fungi (Candida albicans) and only one to Gram-positive bacteria
(MRSE). 82.7% of BSI episodes were due to Gram-negative bacte-
ria, mainly Acinetobacter baumanii, Pseudomonas aeruginosa and
Klebsiella pneumoniae. 62.5% of the isolates were MDR. Of them,
4/8 K. pneumoniae isolates were resistant to carbapenems and sus-
ceptible only to aminoglycosides and colistin, 4/8 P. aeruginosa iso-
lates were susceptible only to piperacillin/tazobactam and colistin
and 3/7 A. baumanii isolates were susceptible only to aminogly-
cosides and colistin. The remaining 4 A. baumanii isolates were
susceptible only to colistin and rifampicin. 17 patients died, 10 of
them due to sepsis-related complications, all having been infected
by MDR Gram-negative bacteria.
Conclusion: In a Greek ICU the incidence of Gram-positive BSIs
remains fairly low compared to data from other countries. While
there is a high frequency of MDR Gram-negative pathogens (simi-
lar in immunocompromised and general ICU patients with BSI), no
bacterial strain has been found resistant to colistin up to date.
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Background: During hospitalization in Intensive Care Unit (ICU),
immunocompromised patients are exposed to resistant bacteria
that may adversely affect their outcome.
Objectives: Data collection and analysis regarding intrahospital in-
fections in immunocompromised patients in a polyvalent 10-bed
ICU of a tertiary care hospital.
Methods: We studied all intrahospital infections in ICU patients
between Aug 2006 and Feb 2008. Blood, urine and bronchial secre-
tions were obtained on clinical suspicion of infection, followed-up
on signs of changes in clinical status.
Results: Among a total of 376 patients that were admitted to ICU
during 18 months, 80 were immunocompromised. 31/80 (38.7%)
developed a nosocomial infection. Mean age was 57.3±14.8 years,
male/female ratio was 22/9, mean APACHE II score was 21±12.9
and average length of stay was 23.1±11 days. The patients were al-
located in 5 categories based on the type of immunodeficiency. 11
patients had undergone solid organ transplantation (8 liver, 3 kid-
ney), 11 patients suffered from malignant disease (7 solid tumors
and 4 hematological malignancies), 2 had been on long-term corti-
costeroids, one was splenectomized and 6 were diabetics. 5 among
them were considered as high-risk (hematological malignancy and
splenectomy), 18 were considered as intermediate risk (solid tu-
mor and organ transplant) and 8 were low-risk (diabetics or on
corticosteroids). Nosocomial infections were consisted of 22 bac-
teremias, 15 ventilator-associated pneumonias, 8 catheter-related
infections, 8 intraabdominal infections, 4 surgical site infections,
3 urinary tract infections, 1 pleural empyema, and 1 soft tissue
infection. The prevalence of Gram-negative bacteria remains high
reaching 80.9% of isolated organisms [12.2% multiresistant (MDR)
Pseudomonas spp., 24.5% MDR A cinetobacter spp. and 14.3% MDR
Klebsiella spp.], while only 11.1% were Gram-positive (none MRSA,
none VRE) and 8% were fungi. Overall mortality among immuno-
compromised patients with infection was 58% with 61.1% of deaths
being sepsis-related as compared to 45% in the general ICU patients
with infection.
Conclusion: Infections in immunocompromised patients is an im-
portant problem in ICU. Mortality in immunocompromised patients
is higher than that in the general ICU patient population and fol-
lows a wide range of nosocomial infections especially due to Gram-
negative bacteria.
